SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 539 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,510 | +1488.0% | 21,258 | +1413.0% | 0.45% | +1634.6% |
| Q1 2023 | $284 | -22.0% | 1,405 | -50.4% | 0.03% | -27.8% |
| Q4 2022 | $364 | -100.0% | 2,831 | -69.3% | 0.04% | -71.0% |
| Q3 2022 | $1,262,000 | +441.6% | 9,220 | +469.1% | 0.12% | +359.3% |
| Q1 2022 | $233,000 | -34.9% | 1,620 | -37.1% | 0.03% | -32.5% |
| Q1 2021 | $358,000 | +76.4% | 2,575 | +121.8% | 0.04% | +21.2% |
| Q4 2020 | $203,000 | – | 1,161 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |